1. |
Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation, 2002, 106(24): 3006-3008.
|
2. |
Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J, 2022, 43(7): 561-632.
|
3. |
Carroll JD, Mack MJ, Vemulapalli S, et al. STS-ACC TVT registry of transcatheter aortic valve replacement. J Am Coll Cardiol, 2020, 76(21): 2492-2516.
|
4. |
Xu H, Liu Q, Cao K, et al. Distribution, characteristics, and management of older patients with valvular heart disease in China: China-DVD Study. JACC Asia, 2022, 2(3): 354-365.
|
5. |
Cannata S, Gandolfo C, Ribichini FL, et al. One-year outcomes after transcatheter aortic valve implantation with the latest-generation SAPIEN balloon-expandable valve: the S3U registry. EuroIntervention, 2023, 18(17): 1418-1427.
|
6. |
Nazif TM, Cahill TJ, Daniels D, et al. Real-world experience with the SAPIEN 3 Ultra transcatheter heart valve: a propensity-matched analysis from the United States. Circ Cardiovasc Interv, 2021, 14(9): e010543.
|
7. |
Tang GHL, Zaid S, Michev I, et al. “Cusp-overlap” view simplifies fluoroscopy-guided implantation of self-expanding valve in transcatheter aortic valve replacement. JACC Cardiovasc Interv, 2018, 11(16): 1663-1665.
|
8. |
Doldi PM, Stolz L, Escher F, et al. Transcatheter aortic valve replacement with the self-expandable Core Valve Evolut prosthesis using the cusp-overlap vs. tricusp-view. J Clin Med, 2022, 11(6): 1561.
|
9. |
Gada H, Vora AN, Tang GHL, et al. Site-level variation and predictors of permanent pacemaker implantation following TAVR in the Evolut low-risk trial. Cardiovasc Revasc Med, 2023, 47: 48-54.
|
10. |
Khera S, Krishnamoorthy P, Sharma SK, et al. Improved commissural alignment in TAVR with the newest Evolut FX self-expanding supra-annular valve: first-in-human experience. JACC Cardiovasc Interv, 2023, 16(4): 498-500.
|
11. |
Merdler I, Case B, Bhogal S, et al. Early experience with the Evolut FX self-expanding valve vs. Evolut PRO+ for patients with aortic stenosis undergoing TAVR. Cardiovasc Revasc Med, 2023: S1553-8389(23)00627-9.
|
12. |
Makkar RR, Cheng W, Waksman R, et al. Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trial. Lancet, 2020, 396(10252): 669-683.
|
13. |
Sondergaard L, Walton AS, Worthley SG, et al. Thirty-day and one-year outcomes of the Navitor transcatheter heart valve in patients with aortic stenosis: the prospective, multicentre, global PORTICO NG Study. EuroIntervention, 2023, 19(3): 248-255.
|
14. |
Tamburino C, Bleiziffer S, Thiele H, et al. Comparison of self-expanding bioprostheses for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: SCOPE 2 randomized clinical trial. Circulation, 2020, 142(25): 2431-2442.
|
15. |
Buono A, Gorla R, Ielasi A, et al. Transcatheter aortic valve replacement with self-expanding ACURATE neo2: postprocedural hemodynamic and short-term clinical outcomes. JACC Cardiovasc Interv, 2022, 15(11): 1101-1110.
|
16. |
Zhou D, Pan W, Wang J, et al. VitaFlowTM transcatheter valve system in the treatment of severe aortic stenosis: one-year results of a multicenter study. Catheter Cardiovasc Interv, 2020, 95(2): 332-338.
|
17. |
杨力凡, 张晓春, 张蕾, 等. VitaFlowTM 经导管瓣膜系统治疗重度主动脉瓣狭窄—多中心 2 年随访结果. 中国介入心脏病学杂志, 2020, 28(6): 316-320.
|
18. |
宋光远, 王墨扬, 王媛, 等. Venus-A 主动脉瓣膜介入治疗重度主动脉瓣狭窄的效果. 中华心血管病杂志, 2017, 45(10): 843-847.
|
19. |
Wang M, Song G, Chen M, et al. Twelve-month outcomes of the TaurusOne valve for transcatheter aortic valve implantation in patients with severe aortic stenosis. EuroIntervention, 2022, 17(13): 1070-1076.
|
20. |
Yoon SH, Schmidt T, Bleiziffer S, et al. Transcatheter aortic valve replacement in pure native aortic valve regurgitation. J Am Coll Cardiol, 2017, 70(22): 2752-2763.
|
21. |
Carroll JD, Mack MJ, Vemulapalli S, et al. STS-ACC TVT Registry of transcatheter aortic valve replacement. Ann Thorac Surg, 2021, 111(2): 701-722.
|
22. |
Kempfert J, Rastan AJ, Mohr FW, et al. A new self-expanding transcatheter aortic valve for transapical implantation - first in man implantation of the JenaValveTM. Eur J Cardiothorac Surg, 2011, 40(3): 761-763.
|
23. |
Nijenhuis VJ, Swaans MJ, Michiels V, et al. “First experience with JenaValveTM: a single-centre cohort”. Neth Heart J, 2015, 23(1): 35-41.
|
24. |
Schäfer U, Schirmer J, Niklas S, et al. First-in-human implantation of a novel transfemoral selfexpanding transcatheter heart valve to treat pure aortic regurgitation. EuroIntervention, 2017, 13(11): 1296-1299.
|
25. |
Vahl T, Makkar R, Kodali S, et al. 30-day outcomes of transfemoral transcatheter aortic valve replacement for aortic regurgitation with a novel self-expanding prosthesis. J Am Coll Cardiol, 2021, 77(18): 919.
|
26. |
Shi J, Wei L, Chen Y, et al. Transcatheter aortic valve implantation with J-Valve: 2-year outcomes from a multicenter study. Ann Thorac Surg, 2021, 111(5): 1530-1536.
|
27. |
Hensey M, Murdoch DJ, Sathananthan J, et al. First-in-human experience of a new-generation transfemoral transcatheter aortic valve for the treatment of severe aortic regurgitation: the J-Valve transfemoral system. EuroIntervention, 2019, 14(15): e1553-e1555.
|
28. |
Rezvova MA, Yuzhalin AE, Glushkova TV, et al. Biocompatible nanocomposites based on poly(styrene-block-isobutylene-block-styrene) and carbon nanotubes for biomedical application. Polymers (Basel), 2020, 12(9): 2158.
|
29. |
Rezvova MA, Nikishau PA, Makarevich MI, et al. Biomaterials based on carbon nanotube nanocomposites of poly(styrene-b-isobutylene-bstyrene): the effect of nanotube content on the mechanical properties, biocompatibility and hemocompatibility. Nanomaterials, 2022, 12(5): 733.
|
30. |
Bui HT, Khair N, Yeats B, et al. Transcatheter heart valves: a biomaterials perspective. Adv Healthc Mater, 2021, 10(15): 2100115.
|
31. |
Li RL, Russ J, Paschalides C, et al. Mechanical considerations for polymeric heart valve development: biomechanics, materials, design and manufacturing. Biomaterials, 2019, 225: 119493.
|
32. |
Oveissi F, Naficy S, Lee A, et al. Materials and manufacturing perspectives in engineering heart valves: a review. Mater Today Bio, 2020, 5: 100038.
|
33. |
Kereiakes DJ, Answini GA, Yakubov SJ, et al. Preliminary evaluation of a novel polymeric valve following surgical implantation for symptomatic aortic valve disease. JACC Cardiovasc Interv, 2021, 14(24): 2754-2756.
|